• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将McoTI-II刚性分子支架重新用作“木瓜蛋白酶超家族”半胱氨酸蛋白酶的抑制剂。

Repurposing the McoTI-II Rigid Molecular Scaffold in to Inhibitor of 'Papain Superfamily' Cysteine Proteases.

作者信息

Mishra Manasi, Singh Vigyasa, Tellis Meenakshi B, Joshi Rakesh S, Singh Shailja

机构信息

Department of Life Sciences, School of Natural Sciences, Shiv Nadar University, Gautam Buddha Nagar 201314, India.

Special Centre for Molecular Medicine, Jawahar Lal Nehru University, New Delhi 110067, India.

出版信息

Pharmaceuticals (Basel). 2020 Dec 23;14(1):7. doi: 10.3390/ph14010007.

DOI:10.3390/ph14010007
PMID:33374547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7822474/
Abstract

Clan C1A or 'papain superfamily' cysteine proteases are key players in many important physiological processes and diseases in most living systems. Novel approaches towards the development of their inhibitors can open new avenues in translational medicine. Here, we report a novel design of a re-engineered chimera inhibitor Mco-cysteine protease inhibitor (CPI) to inhibit the activity of C1A cysteine proteases. This was accomplished by grafting the cystatin first hairpin loop conserved motif (QVVAG) onto loop 1 of the ultrastable cyclic peptide scaffold McoTI-II. The recombinantly expressed Mco-CPI protein was able to bind with micromolar affinity to papain and showed remarkable thermostability owing to the formation of multi-disulphide bonds. Using an in silico approach based on homology modelling, protein-protein docking, the calculation of the free-energy of binding, the mechanism of inhibition of Mco-CPI against representative C1A cysteine proteases (papain and cathepsin L) was validated. Furthermore, molecular dynamics simulation of the Mco-CPI-papain complex validated the interaction as stable. To conclude, in this McoTI-II analogue, the specificity had been successfully redirected towards C1A cysteine proteases while retaining the moderate affinity. The outcomes of this study pave the way for further modifications of the Mco-CPI design for realizing its full potential in therapeutics. This study also demonstrates the relevance of ultrastable peptide-based scaffolds for the development of novel inhibitors via grafting.

摘要

C1A家族或“木瓜蛋白酶超家族”半胱氨酸蛋白酶是大多数生命系统中许多重要生理过程和疾病的关键参与者。开发其抑制剂的新方法可为转化医学开辟新途径。在此,我们报告了一种重新设计的嵌合抑制剂Mco-半胱氨酸蛋白酶抑制剂(CPI)的新设计,以抑制C1A半胱氨酸蛋白酶的活性。这是通过将胱抑素的第一个发夹环保守基序(QVVAG)嫁接到超稳定环肽支架McoTI-II的环1上来实现的。重组表达的Mco-CPI蛋白能够以微摩尔亲和力与木瓜蛋白酶结合,并且由于形成了多个二硫键而表现出显著的热稳定性。使用基于同源建模、蛋白质-蛋白质对接、结合自由能计算的计算机模拟方法,验证了Mco-CPI对代表性C1A半胱氨酸蛋白酶(木瓜蛋白酶和组织蛋白酶L)的抑制机制。此外,Mco-CPI-木瓜蛋白酶复合物的分子动力学模拟验证了这种相互作用是稳定的。总之,在这种McoTI-II类似物中,特异性已成功重新定向至C1A半胱氨酸蛋白酶,同时保留了适度的亲和力。本研究结果为进一步修饰Mco-CPI设计以实现其在治疗中的全部潜力铺平了道路。本研究还证明了超稳定肽基支架通过嫁接开发新型抑制剂的相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/7822474/dd74e48d4a2c/pharmaceuticals-14-00007-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/7822474/d5b1d38bb5de/pharmaceuticals-14-00007-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/7822474/d975ca12fd19/pharmaceuticals-14-00007-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/7822474/591bf3c49370/pharmaceuticals-14-00007-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/7822474/f339bf288b4c/pharmaceuticals-14-00007-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/7822474/163889f7ca4c/pharmaceuticals-14-00007-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/7822474/7e8410871de4/pharmaceuticals-14-00007-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/7822474/dd74e48d4a2c/pharmaceuticals-14-00007-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/7822474/d5b1d38bb5de/pharmaceuticals-14-00007-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/7822474/d975ca12fd19/pharmaceuticals-14-00007-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/7822474/591bf3c49370/pharmaceuticals-14-00007-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/7822474/f339bf288b4c/pharmaceuticals-14-00007-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/7822474/163889f7ca4c/pharmaceuticals-14-00007-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/7822474/7e8410871de4/pharmaceuticals-14-00007-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8e0/7822474/dd74e48d4a2c/pharmaceuticals-14-00007-g007.jpg

相似文献

1
Repurposing the McoTI-II Rigid Molecular Scaffold in to Inhibitor of 'Papain Superfamily' Cysteine Proteases.将McoTI-II刚性分子支架重新用作“木瓜蛋白酶超家族”半胱氨酸蛋白酶的抑制剂。
Pharmaceuticals (Basel). 2020 Dec 23;14(1):7. doi: 10.3390/ph14010007.
2
Evidence that serpin architecture intrinsically supports papain-like cysteine protease inhibition: engineering alpha(1)-antitrypsin to inhibit cathepsin proteases.丝氨酸蛋白酶抑制剂结构本质上支持木瓜蛋白酶样半胱氨酸蛋白酶抑制作用的证据:工程化α1-抗胰蛋白酶以抑制组织蛋白酶。
Biochemistry. 2002 Apr 16;41(15):4998-5004. doi: 10.1021/bi0159985.
3
Cyclic peptide engineered from phytocystatin inhibitory hairpin loop as an effective modulator of falcipains and potent antimalarial.基于植物半胱氨酸蛋白酶抑制剂发夹环环肽工程改造作为疟原虫裂殖体蛋白强效调节剂和抗疟药物
J Biomol Struct Dyn. 2022 May;40(8):3642-3654. doi: 10.1080/07391102.2020.1848629. Epub 2020 Dec 9.
4
Hybrids of chicken cystatin with human kininogen domain 2 sequences exhibit novel inhibition of calpain, improved inhibition of actinidin and impaired inhibition of papain, cathepsin L and cathepsin B.鸡半胱氨酸蛋白酶抑制剂与人类激肽原结构域2序列的杂合体对钙蛋白酶表现出新型抑制作用,对肌动蛋白酶的抑制作用增强,而对木瓜蛋白酶、组织蛋白酶L和组织蛋白酶B的抑制作用受损。
Eur J Biochem. 1996 Feb 1;235(3):534-42. doi: 10.1111/j.1432-1033.1996.00534.x.
5
Giardia intestinalis cystatin is a potent inhibitor of papain, parasite cysteine proteases and, to a lesser extent, human cathepsin B.肠道贾第虫半胱氨酸蛋白酶抑制剂是木瓜蛋白酶、寄生虫半胱氨酸蛋白酶的强抑制剂,在较小程度上也是人组织蛋白酶 B 的抑制剂。
FEBS Lett. 2019 Jun;593(12):1313-1325. doi: 10.1002/1873-3468.13433. Epub 2019 May 22.
6
Phage display selection of hairpin loop soyacystatin variants that mediate high affinity inhibition of a cysteine proteinase.通过噬菌体展示筛选介导对半胱氨酸蛋白酶高亲和力抑制作用的发夹环大豆半胱氨酸蛋白酶抑制剂变体。
Plant J. 2001 Sep;27(5):383-91. doi: 10.1046/j.1365-313x.2001.01104.x.
7
Binding modes of a new epoxysuccinyl-peptide inhibitor of cysteine proteases. Where and how do cysteine proteases express their selectivity?一种新型半胱氨酸蛋白酶环氧琥珀酰肽抑制剂的结合模式。半胱氨酸蛋白酶在何处以及如何表现出其选择性?
Biochim Biophys Acta. 1999 May 18;1431(2):290-305. doi: 10.1016/s0167-4838(99)00053-9.
8
Revealing the inhibitory potential of Yersinia enterocolitica on cysteine proteases of the papain family.揭示肠炎沙门氏菌对木瓜蛋白酶家族半胱氨酸蛋白酶的抑制潜力。
Microbiol Res. 2018 Mar;207:211-225. doi: 10.1016/j.micres.2017.12.005. Epub 2017 Dec 8.
9
Modelling family 2 cystatins and their interaction with papain.模拟家族 2 半胱氨酸蛋白酶抑制剂及其与木瓜蛋白酶的相互作用。
J Biomol Struct Dyn. 2013;31(6):649-64. doi: 10.1080/07391102.2012.706403. Epub 2012 Aug 13.
10
Differential effect toward inhibition of papain and cathepsin C by recombinant human salivary cystatin SN and its variants produced by a baculovirus system.重组人唾液胱抑素SN及其杆状病毒系统产生的变体对木瓜蛋白酶和组织蛋白酶C抑制作用的差异效应。
Arch Biochem Biophys. 2000 Aug 1;380(1):133-40. doi: 10.1006/abbi.2000.1909.

引用本文的文献

1
The effects of free Cys residues on the structure, activity, and tetrameric stability of mammalian uricase.游离半胱氨酸残基对哺乳动物尿酸酶结构、活性和四聚体稳定性的影响。
Appl Microbiol Biotechnol. 2023 Jul;107(14):4533-4542. doi: 10.1007/s00253-023-12597-y. Epub 2023 May 31.
2
Antimicrobial Peptides: Challenging Journey to the Pharmaceutical, Biomedical, and Cosmeceutical Use.抗菌肽:走向医药、生物医学和化妆品应用的挑战之旅。
Int J Mol Sci. 2023 May 20;24(10):9031. doi: 10.3390/ijms24109031.
3
Plant derived cyclic peptides.植物来源的环肽。

本文引用的文献

1
Cysteine Cathepsin Protease Inhibition: An update on its Diagnostic, Prognostic and Therapeutic Potential in Cancer.半胱氨酸组织蛋白酶蛋白酶抑制作用:关于其在癌症中的诊断、预后及治疗潜力的最新进展
Pharmaceuticals (Basel). 2019 Jun 11;12(2):87. doi: 10.3390/ph12020087.
2
Application of a label-free and domain-specific free thiol method in monoclonal antibody characterization.无标记和特定结构域游离巯基方法在单克隆抗体表征中的应用。
J Chromatogr B Analyt Technol Biomed Life Sci. 2019 May 1;1114-1115:93-99. doi: 10.1016/j.jchromb.2019.03.032. Epub 2019 Mar 26.
3
Cysteine Cathepsins and their Extracellular Roles: Shaping the Microenvironment.
Biochem Soc Trans. 2021 Jun 30;49(3):1279-1285. doi: 10.1042/BST20200881.
4
Mechanisms Applied by Protein Inhibitors to Inhibit Cysteine Proteases.蛋白质抑制剂抑制半胱氨酸蛋白酶的作用机制。
Int J Mol Sci. 2021 Jan 20;22(3):997. doi: 10.3390/ijms22030997.
半胱氨酸组织蛋白酶及其细胞外作用:塑造微环境。
Cells. 2019 Mar 20;8(3):264. doi: 10.3390/cells8030264.
4
Structural Insights Into Key Proteases as Therapeutic Drug Targets.作为治疗药物靶点的关键蛋白酶的结构洞察
Front Microbiol. 2019 Mar 5;10:394. doi: 10.3389/fmicb.2019.00394. eCollection 2019.
5
Proteases: History, discovery, and roles in health and disease.蛋白酶:历史、发现及在健康和疾病中的作用。
J Biol Chem. 2019 Feb 1;294(5):1643-1651. doi: 10.1074/jbc.TM118.004156.
6
Engineering varied serine protease inhibitors by converting P1 site of BF9, a weakly active Kunitz-type animal toxin.通过转换 BF9 的 P1 位,即一个弱活性的 Kunitz 型动物毒素,来工程化多样化的丝氨酸蛋白酶抑制剂。
Int J Biol Macromol. 2018 Dec;120(Pt A):1190-1197. doi: 10.1016/j.ijbiomac.2018.08.178. Epub 2018 Aug 30.
7
Cysteine proteases in protozoan parasites.原虫寄生虫中的半胱氨酸蛋白酶。
PLoS Negl Trop Dis. 2018 Aug 23;12(8):e0006512. doi: 10.1371/journal.pntd.0006512. eCollection 2018 Aug.
8
The diverse roles of cysteine proteases in parasites and their suitability as drug targets.半胱氨酸蛋白酶在寄生虫中的多种作用及其作为药物靶点的适用性。
PLoS Negl Trop Dis. 2018 Aug 23;12(8):e0005639. doi: 10.1371/journal.pntd.0005639. eCollection 2018 Aug.
9
The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database.MEROPS 数据库收录了 2017 年的蛋白水解酶、其底物和抑制剂,以及与 PANTHER 数据库中肽酶的比较。
Nucleic Acids Res. 2018 Jan 4;46(D1):D624-D632. doi: 10.1093/nar/gkx1134.
10
In vitro-engineered non-antibody protein therapeutics.体外工程化的非抗体蛋白治疗药物。
Protein Cell. 2018 Jan;9(1):3-14. doi: 10.1007/s13238-017-0386-6. Epub 2017 Mar 7.